Status and phase
Conditions
Treatments
About
The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.
Full description
During this intervention study, subjects will receive either a placebo or Endocalyx for 12 weeks. The main objective of this study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.
Secondary objectives are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Treatment resistant hypertension defined as
Stable diuretic and antihypertensive treatment for the previous 3 weeks.
Subject, or legal representative, has voluntarily signed and dated an Informed Consent Form, approved by the Independent Ethics Committee (IEC).
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
64 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Rik Olde Engberink, MD PhD; Sanédy Simon, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal